These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 8327024)

  • 1. Incidence of Guillain-Barré syndrome and ganglioside intake in Alcoi, Spain.
    Matias-Guiu J; Martin R; Blanquer J; Gonzalez MJ; Falip R; Oltra A; Moltó JM
    Neuroepidemiology; 1993; 12(1):58-60. PubMed ID: 8327024
    [No Abstract]   [Full Text] [Related]  

  • 2. Gangliosides and Guillain-Barré syndrome: the Spanish data.
    Díez-Tejedor E; Gutiérrez-Rivas E; Gil-Peralta A
    Neuroepidemiology; 1993; 12(5):251-6. PubMed ID: 8309499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exogenous gangliosides and Guillain-Barré syndrome. An observational study in the local health district of Ferrara, Italy.
    Govoni V; Granieri E; Tola MR; Paolino E; Casetta I; Fainardi E; Monetti VC
    Brain; 1997 Jul; 120 ( Pt 7)():1123-30. PubMed ID: 9236625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guillain-Barré syndrome in Cantabria, Spain. An epidemiological and clinical study.
    Sedano MJ; Calleja J; Canga E; Berciano J
    Acta Neurol Scand; 1994 Apr; 89(4):287-92. PubMed ID: 8042448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gangliosides and Guillain-Barré syndrome. Apparent association is a coincidence.
    Grigoletto F
    BMJ; 1994 Mar; 308(6929):653-4. PubMed ID: 8148725
    [No Abstract]   [Full Text] [Related]  

  • 6. Increased incidence of Guillain-Barré syndrome postpartum.
    Cheng Q; Jiang GX; Fredrikson S; Link H; de Pedro-Cuesta J
    Epidemiology; 1998 Nov; 9(6):601-4. PubMed ID: 9799167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gangliosides and Guillain-Barré syndrome. No causal link.
    Samson JC; Fiori MG
    BMJ; 1994 Mar; 308(6929):653. PubMed ID: 8148723
    [No Abstract]   [Full Text] [Related]  

  • 8. Gangliosides and Guillain-Barré syndrome.
    Raschetti R; Maggini M; Popoli P; Caffari B; Da Cas R; Menniti-Ippolito F; Spila-Alegiani S; Traversa G
    J Clin Epidemiol; 1995 Nov; 48(11):1399-405. PubMed ID: 7490603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Gangliosides and the Guillain-Barré syndrome].
    Berciano J
    Med Clin (Barc); 1993 Dec; 101(19):758-9. PubMed ID: 8289527
    [No Abstract]   [Full Text] [Related]  

  • 10. Guillain-Barré syndrome and ganglioside therapy in Italy.
    Raschetti R; Maggini M; Popoli P
    Lancet; 1992 Jul; 340(8810):60. PubMed ID: 1351644
    [No Abstract]   [Full Text] [Related]  

  • 11. Ganglioside therapy and Guillain-Barré syndrome. A historical cohort study in Ferrara, Italy, fails to demonstrate an association.
    Granieri E; Casetta I; Govoni V; Tola MR; Paolino E; Rocca WA
    Neuroepidemiology; 1991; 10(4):161-9. PubMed ID: 1745325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guillain-Barré syndrome after exogenous gangliosides in Italy.
    Landi G; D'Alessandro R; Dossi BC; Ricci S; Simone IL; Ciccone A
    BMJ; 1993 Dec; 307(6917):1463-4. PubMed ID: 8281088
    [No Abstract]   [Full Text] [Related]  

  • 13. [Relationship between parenteral gangliosides administration and the Guillain-Barré syndrome].
    Conceição I; Carvalho M; Alves M; Parreira E; Martins A; Ferro J; Sales-Luis ML
    Rev Neurol; 1999 Jun 1-15; 28(11):1033-5. PubMed ID: 10390766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines.
    Lasky T; Terracciano GJ; Magder L; Koski CL; Ballesteros M; Nash D; Clark S; Haber P; Stolley PD; Schonberger LB; Chen RT
    N Engl J Med; 1998 Dec; 339(25):1797-802. PubMed ID: 9854114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Etiological mechanism and treatment of Guillain-Barre syndrome-- Campylobacter jejuni enteritis and the development of anti-ganglioside antibody preceding the syndrome].
    Yuki N
    Nihon Naika Gakkai Zasshi; 1998 Apr; 87(4):612-6. PubMed ID: 9627467
    [No Abstract]   [Full Text] [Related]  

  • 16. Guillain-Barré syndrome and parenteral gangliosides.
    Lancet; 1991 Sep; 338(8769):757. PubMed ID: 1679886
    [No Abstract]   [Full Text] [Related]  

  • 17. Guillain-Barré syndrome: diagnostic criteria, epidemiology, clinical course and prognosis.
    Hallas J; Bredkjaer C; Friis ML
    Acta Neurol Scand; 1988 Aug; 78(2):118-22. PubMed ID: 3262981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exposure to exogenous gangliosides and Guillain-Barré syndrome.
    Beghi E
    Neuroepidemiology; 1995; 14(2):45-8. PubMed ID: 7891813
    [No Abstract]   [Full Text] [Related]  

  • 19. Acute axonal Guillain-Barré syndrome with IgG antibodies against motor axons following parenteral gangliosides.
    Illa I; Ortiz N; Gallard E; Juarez C; Grau JM; Dalakas MC
    Ann Neurol; 1995 Aug; 38(2):218-24. PubMed ID: 7654069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guillain-Barré syndrome in South-West Stockholm, 1973-1991, 3. Clinicoepidemiological subgroups.
    de Pedro-Cuesta J; Abraira V; Jiang GX; Solders G; Fredrikson S
    Acta Neurol Scand; 1996; 93(2-3):175-83. PubMed ID: 8741139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.